Enliven Therapeutics, Inc. ($ELVN)
Filing Information
| Accession Number | 0001882764-26-000006 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 21, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
8,162
Total Value
$319,438.89
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF FINANCIAL OFFICER | Common Stock | โ | Jul 17, 2026 | Exercise/Conversion | 1,072 | $2.48 | $2,658.56 | 52,072 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Common Stock | โ | Jul 17, 2026 | Sale | 324 | $49.97 | $16,190.77 | 51,748 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Common Stock | โ | Jul 17, 2026 | Sale | 369 | $51.48 | $18,996.97 | 51,379 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Common Stock | โ | Jul 17, 2026 | Sale | 2,564 | $52.32 | $134,143.35 | 48,815 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Common Stock | โ | Jul 17, 2026 | Sale | 2,638 | $53.38 | $140,823.04 | 46,177 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Common Stock | โ | Jul 17, 2026 | Sale | 123 | $53.87 | $6,626.21 | 46,054 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Stock Option (right to buy) | Derivative | Jul 17, 2026 | Exercise/Conversion | 1,072 | $0.00 | $0.00 | 84,966 | Direct | โ | View Details |